000 | 01031 a2200277 4500 | ||
---|---|---|---|
005 | 20250516140136.0 | ||
264 | 0 | _c20140110 | |
008 | 201401s 0 0 eng d | ||
022 | _a1872-8227 | ||
024 | 7 |
_a10.1016/j.diabres.2013.01.025 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aChoukem, Simeon-Pierre | |
245 | 0 | 0 |
_aShould we still screen for type 2 diabetes after ADDITION-Cambridge? A low-income world perspective. _h[electronic resource] |
260 |
_bDiabetes research and clinical practice _cMay 2013 |
||
300 |
_a282-4 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aCost-Benefit Analysis |
650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xdiagnosis |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMass Screening |
650 | 0 | 4 | _aPrimary Health Care |
650 | 0 | 4 | _aRisk Factors |
700 | 1 | _aMbanya, Jean-Claude | |
773 | 0 |
_tDiabetes research and clinical practice _gvol. 100 _gno. 2 _gp. 282-4 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.diabres.2013.01.025 _zAvailable from publisher's website |
999 |
_c22554782 _d22554782 |